Skip to content
Open access · CC-BY via OpenAlex

Metabolic and Neuroendocrine Responses to Intermittent Fasting in Obesity

Salvatore Allocca, Antonietta Monda, Maria Casillo, Fiorenzo Moscatelli, Marco La Marra, Vincenzo Monda, Girolamo Di Maio, Raffaele Ivan Cincione, Paride Vasco, Marcellino Monda, Rita Polito, Giovanni Messina, Antonietta Messina

Medicina · 2026

Abstract

Background and Objectives: Intermittent fasting (IF) has emerged as a nutritional strategy capable of modulating circadian alignment, metabolic efficiency, and neuroendocrine regulation in individuals with obesity. Among the neurobiological mediators potentially involved, Orexin-A—a hypothalamic neuropeptide regulating arousal, appetite, and energy balance—may represent a key link between fasting patterns and metabolic homeostasis. This study aimed to evaluate the long-term metabolic and neuroendocrine effects of two intermittent fasting protocols, time-restricted feeding (16:8) and alternate-day fasting (5:2), compared with a hypocaloric Mediterranean diet used as a reference condition. Materials and Methods: Thirty adults with obesity (aged 20–40 years) were allocated to one of three dietary interventions—low-calorie Mediterranean diet, IF 16:8, or IF 5:2—based on habitual dietary patterns and followed prospectively for 12 months. Anthropometric parameters, metabolic indices, inflammatory markers (CRP, TNF-α, IL-6, IL-10), and circulating Orexin-A concentrations were assessed at baseline and at three-month intervals (T0–T3). Results: Both intermittent fasting protocols induced more rapid improvements in body mass index, adiposity, lipid profile, fasting glucose, and inflammatory markers compared with the Mediterranean diet. Among the IF strategies, the 16:8 regimen showed the most consistent and physiologically coherent pattern of adaptation, characterized by a progressive and sustained increase in Orexin-A levels. This response was strongly associated with enhanced metabolic flexibility, reduced systemic inflammation, and improved energy regulation over time. In contrast, the 5:2 protocol produced more variable metabolic and neuroendocrine responses, likely due to alternating cycles of marked caloric restriction(definition) and compensatory intake. Conclusions: Intermittent fasting, particularly the 16:8 time-restricted feeding protocol, appears to be an effective and sustainable chrononutritional strategy for obesity management. By reinforcing circadian organization, improving inflammatory balance, and activating orexinergic pathways, the 16:8 model emerges as a promising intervention to address key metabolic and neuroendocrine dysfunctions associated with obesity.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.3390/medicina62020255
Canonical
link ↗
Fetched
2026-11-08 MST

Cite this

APA
Allocca, S., Monda, A., Casillo, M., Moscatelli, F., Marra, M.L., Monda, V., Maio, G.D., Cincione, R.I., Vasco, P., Monda, M., Polito, R., Messina, G., &amp; Messina, A. (2026). Metabolic and Neuroendocrine Responses to Intermittent Fasting in Obesity. <em>Medicina</em>. https://doi.org/10.3390/medicina62020255
Vancouver
Allocca S, Monda A, Casillo M, Moscatelli F, Marra ML, Monda V, et al. Metabolic and Neuroendocrine Responses to Intermittent Fasting in Obesity. Medicina. 2026. doi:10.3390/medicina62020255.
BibTeX
@article{salvatore2026Metabo, title = {Metabolic and Neuroendocrine Responses to Intermittent Fasting in Obesity}, author = {Salvatore Allocca and Antonietta Monda and Maria Casillo and Fiorenzo Moscatelli and Marco La Marra and Vincenzo Monda and Girolamo Di Maio and Raffaele Ivan Cincione and Paride Vasco and Marcellino Monda and Rita Polito and Giovanni Messina and Antonietta Messina}, journal = {Medicina}, year = {2026}, doi = {10.3390/medicina62020255}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings